tiprankstipranks
IGC Pharma (DE:IGS1)
FRANKFURT:IGS1
Germany Market
IGS1
IGC Pharma
RESEARCH TOOLSreports

IGC Pharma (IGS1) Stock Forecast & Price Target

6 Followers
See the Price Targets and Ratings of:

IGS1 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
IGC
Pharma
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

IGS1 Stock 12 Month Forecast

There Are No Analyst Ratings for DE:IGS1 In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

IGS1 Financial Forecast

IGS1 Earnings Forecast

Next quarter’s earnings estimate for IGS1 is -€0.02 with a range of -€0.02 to -€0.02. The previous quarter’s EPS was -€0.02. IGS1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year IGS1 has Performed in-line its overall industry.
Next quarter’s earnings estimate for IGS1 is -€0.02 with a range of -€0.02 to -€0.02. The previous quarter’s EPS was -€0.02. IGS1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year IGS1 has Performed in-line its overall industry.

IGS1 Sales Forecast

Next quarter’s sales forecast for IGS1 is €82.67K with a range of €82.67K to €82.67K. The previous quarter’s sales results were €272.97K. IGS1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year IGS1 has Performed in-line its overall industry.
Next quarter’s sales forecast for IGS1 is €82.67K with a range of €82.67K to €82.67K. The previous quarter’s sales results were €272.97K. IGS1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year IGS1 has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Ascendiant Analyst forecast on DE:IGS1
Edward Woo
Ascendiant
Ascendiant
€4.52→€4.74
Buy
1721.58%
Upside
Reiterated
06/05/26
Current valuation attractive: We are maintaining our Buy rating, but raising our 12‐month price target to $5.50 from $5.25, based on a NPV analysis, representing significant upside from the current share price.
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Ascendiant Analyst forecast on DE:IGS1
Edward Woo
Ascendiant
Ascendiant
€4.52→€4.74
Buy
1721.58%
Upside
Reiterated
06/05/26
Current valuation attractive: We are maintaining our Buy rating, but raising our 12‐month price target to $5.50 from $5.25, based on a NPV analysis, representing significant upside from the current share price.
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering IGC Pharma

3 Months
Edward WooAscendiant
Success Rate
6/10 ratings generated profit
60%
Average Return
+4.69%
Copying Edward Woo's trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +4.69% per trade.
1 Year
Edward WooAscendiant
Success Rate
6/10 ratings generated profit
60%
Average Return
-1.51%
Copying Edward Woo's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of -1.51% per trade.
2 Years
Edward WooAscendiant
Success Rate
5/10 ratings generated profit
50%
Average Return
-8.21%
Copying Edward Woo's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -8.21% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

IGS1 Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
1
2
1
1
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
2
1
1
0
In the current month, IGS1 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IGS1 average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

IGS1 Stock Forecast FAQ

What is DE:IGS1’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:IGS1’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:IGS1, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is IGC Pharma a Buy, Sell or Hold?
      Currently, no data Available
      What is IGC Pharma’s share price target?
      Currently, no data Available
      What do analysts say about IGC Pharma?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of IGC Pharma?
      To buy shares of DE:IGS1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.